OceansBio is a Korean high-tech startup developing implantable electroceuticals and miniature wearable healthcare devices for neurological and stress-related conditions. Drawing on brain-neural-network research, the company uses electrical stimulation that acts directly on the vagus nerve and conducts joint research with leading domestic university hospitals. Its work spans biomedical engineering, electronics, artificial intelligence and data-driven healthcare.
Venture Business Certification
KSM Registration
Registration
TIPS Startup
Compliance program
First Penguin Guarantee Company
Compliance program
Ybrain, Inc. (주식회사 와이브레인)Established in 2013, Ybrain is a Korean brain-science company known for turning noninvasive neurostimulation research into practical mental-health care at home. Its work connects clinical settings with patients’ homes, including the MFDS-approved MINDD STIM+ depression treatment, while its Daejeon facility supports production of medical devices at more than 10,000 units per month.NEW YORK CITY, NY
BioElectronics CorporationFounded by Andrew J. Whelan in 2000, Frederick-based BioElectronics Corporation develops and manufactures wearable, drug-free electroceutical devices that use pulsed shortwave therapy for pain management. The company operates as an OEM and works with commercial and international partners to bring its ActiPatch and RecoveryRx devices to consumer and clinical markets, with four FDA 510(k) clearances and published randomized clinical research supporting its technology.JEFFERSON, MD
Neurosteer IncFounded in 2015 by Tel Aviv University professor Nathan Intrator, Neurosteer develops a wearable, medical-grade brain-activity interpretation platform built around a pocket-sized, single-channel EEG monitor. Its wireless forehead sensor and cloud-based analysis provide real-time brain metrics for clinical assessment, continuous monitoring and research, and the device has FDA Class II clearance. Neurosteer’s teams work across New York, California and Israel, drawing on expertise in neuroscience and signal processing.NEW YORK, NY
Cymbathera ABFounded by scientists from Karolinska Institutet and the Feinstein Institute for Medical Research, Cymbathera AB develops a non-invasive bioelectronic medical device for targeted vagus nerve stimulation to help relieve pain and regulate chronic inflammation. The Lund-based company builds on decades of neuroimmunology research, including Kevin Tracey’s discovery of the inflammatory reflex, and is translating that work into a drug-free approach delivered through the ear’s cymba conchae. Its investigational device remains under clinical and regulatory evaluation.